Page last updated: 2024-11-04

sulfasalazine and Keratoconjunctivitis Sicca

sulfasalazine has been researched along with Keratoconjunctivitis Sicca in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Keratoconjunctivitis Sicca: Drying and inflammation of the conjunctiva as a result of insufficient lacrimal secretion. When found in association with XEROSTOMIA and polyarthritis, it is called SJOGREN'S SYNDROME.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnett, KC1

Other Studies

1 other study available for sulfasalazine and Keratoconjunctivitis Sicca

ArticleYear
Keratoconjunctivitis sicca and the treatment of canine colitis.
    The Veterinary record, 1986, Oct-04, Volume: 119, Issue:14

    Topics: Aminosalicylic Acids; Animals; Colitis; Dog Diseases; Dogs; Female; Keratoconjunctivitis; Keratoconj

1986